BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22296862)

  • 1. Sclerosing mediastinitis and mast cell activation syndrome.
    Afrin LB
    Pathol Res Pract; 2012 Mar; 208(3):181-5. PubMed ID: 22296862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mast cell activation syndromes: impact of pathology and immunohistology.
    Horny HP; Sotlar K; Valent P
    Int Arch Allergy Immunol; 2012; 159(1):1-5. PubMed ID: 22555026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obstruction of the superior vena cava caused by sclerosing mediastinitis. Surgical treatment by bypass with a composite spiral venous graft].
    Fundarò P; Salati M; Botta M; Santoli C
    G Ital Cardiol; 1984 Aug; 14(8):606-8. PubMed ID: 6389248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases.
    Afrin LB; Pöhlau D; Raithel M; Haenisch B; Dumoulin FL; Homann J; Mauer UM; Harzer S; Molderings GJ
    Brain Behav Immun; 2015 Nov; 50():314-321. PubMed ID: 26162709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell activation syndromes: definition and classification.
    Valent P
    Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Wegener's granulomatosis with fibrosing mediastinitis and vena cava superior syndrome.
    Matousovic K; Martinek V; Spatenka J; Stejskal J; Chadimova M
    Ren Fail; 2012; 34(2):244-6. PubMed ID: 22260549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
    Afrin LB; Dempsey TT; Rosenthal LS; Dorff SR
    J Obstet Gynaecol; 2019 Jul; 39(5):664-669. PubMed ID: 30964355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic mast cell activation syndrome and radiation therapy: a case study, literature review, and discussion of mast cell disorders and radiotherapy.
    Landy RE; Stross WC; May JM; Kaleem TA; Malouff TD; Waddle MR; Vallow LA
    Radiat Oncol; 2019 Dec; 14(1):222. PubMed ID: 31818306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal compression syndromes due to idiopathic fibrosing mediastinitis--report of three cases and review of the literature.
    Kalweit G; Huwer H; Straub U; Gams E
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):105-9. PubMed ID: 8782338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular symptoms in patients with systemic mast cell activation disease.
    Kolck UW; Haenisch B; Molderings GJ
    Transl Res; 2016 Aug; 174():23-32.e1. PubMed ID: 26775802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burning mouth syndrome and mast cell activation disorder.
    Afrin LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):465-72. PubMed ID: 21420635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell activation syndrome masquerading as agranulocytosis.
    Afrin LB
    Mil Med; 2012 Jan; 177(1):113-7. PubMed ID: 22338992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior vena cava syndrome due to chronic granulomatous mediastinitis.
    Zufferey P; Chapuis L; Monti M
    Vasa; 1990; 19(4):341-4. PubMed ID: 2291317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases.
    Matito A; Álvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L
    Int Arch Allergy Immunol; 2011; 156(1):104-11. PubMed ID: 21447966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior vena cava syndrome caused by an idiopathic localized form of mediastinal fibrosis.
    Gorospe Sarasúa L; Picón Serrano C; Muñoz Molina GM
    Arch Bronconeumol; 2016 Jan; 52(1):53-5. PubMed ID: 25446867
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome.
    Rønnov-Jessen D; Løvgreen Nielsen P; Horn T
    Bone Marrow Transplant; 1991 Nov; 8(5):413-5. PubMed ID: 1768977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral breast enlargement: an unusual presentation of superior vena cava obstruction in a hemodialysis patient with fibrosing mediastinitis.
    Goo DE; Kim YJ; Choi DL; Kwon KH; Yang SB
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S195-7. PubMed ID: 19949792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review.
    Dorff SR; Afrin LB
    J Obstet Gynaecol; 2020 Oct; 40(7):889-901. PubMed ID: 32148151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.